Nobel Prize Recognizes Pioneering Body's Defenses Research
This year's prestigious award in Physiology or Medicine has been awarded for revolutionary findings that clarify how the body's defense network targets harmful pathogens while protecting the healthy tissues.
Three esteemed researchers—from Japan Prof. Sakaguchi and American scientists Dr. Brunkow and Fred Ramsdell—received this honor.
Their work uncovered specialized "sentinels" within the immune system that eliminate malfunctioning defense cells capable of attacking the organism.
The discoveries are now paving the way for innovative treatments for immune disorders and malignancies.
The winners will share a monetary award worth 11m Swedish kronor.
Decisive Findings
"Their work has been decisive for understanding how the body's defenses operates and the reason we don't all develop serious self-attack conditions," stated the chair of the award panel.
This trio's studies address a fundamental mystery: In what way does the immune system defend us from numerous infections while keeping our healthy cells intact?
Our body's protection system employs immune cells that scan for signs of disease, including pathogens and bacteria it has never encountered.
These cells utilize detectors—called recognition units—that are produced by chance in a vast number of combinations.
That provides the immune system the capacity to fight a broad range of invaders, but the randomness of the mechanism unavoidably produces immune cells that can target the body.
Security Guards of the Body
Researchers previously understood that some of these harmful white blood cells were eliminated in the thymus—where white blood cells mature.
The latest Nobel Prize honors the discovery of T-reg cells—described as the immune system's "security guards"—which patrol the body to disarm other immune cells that assault the healthy cells.
It is known that this mechanism malfunctions in autoimmune diseases such as juvenile diabetes, MS, and RA.
The Nobel panel stated, "These discoveries have laid the foundation for a novel area of investigation and accelerated the development of innovative treatments, for instance for cancer and immune disorders."
Regarding malignancies, T-regs block the body from fighting the tumor, so studies are aimed at reducing their quantity.
For autoimmune diseases, experiments are exploring boosting regulatory T-cells so the organism is not being harmed. A similar method could also be effective in reducing the risks of organ transplant failure.
Innovative Studies
Professor Shimon Sakaguchi, from a Japanese institution, conducted tests on rodents that had their immune gland extracted, causing self-attack conditions.
The researcher demonstrated that injecting immune cells from other animals could prevent the illness—implying there was a mechanism for blocking immune cells from attacking the body.
Dr. Brunkow, from the Institute for Systems Biology in Seattle, and Fred Ramsdell, now at a biotech firm in a California city, were investigating an genetic immune disorder in mice and humans that led to the identification of a genetic factor critical for the way regulatory T-cells function.
"Their pioneering research has revealed how the body's defenses is controlled by T-reg cells, preventing it from mistakenly targeting the healthy cells," said a leading physiology specialist.
"This research is a striking example of how basic physiological research can have far-reaching consequences for public health."
